A Model to Save Lives Through a Volunteer First Responder Service Providing Antidote Treatment in Opioid Overdose
NCT07079241 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000
Last updated 2025-12-17
Summary
Opioids are responsible for the greatest drug-related global health burden. Prevention and treatment programs for people with opioid use disorder are widely implemented, but further actions are required to reduce the mortality and morbidity caused by opioid use and dependence. We suggest a novel and unique approach with a volunteer first responder system for suspected opioid overdoses, integrated with national emergency call services. The idea derives from the success of volunteer first responder systems for out-of-hospital cardiac arrests. Several reports exist globally with results of increased survival rates, less complications and a beneficial time-gain to start of cardiopulmonary resuscitation before emergency services (like ambulance and fire fighters) arrival.
Our model aims to investigate feasibility, acceptability and safety of a smartphone-based volunteer first responder system for suspected opioid overdoses. The volunteer responders will be equipped with an emergency kit including two doses of the opioid antidote naloxone, which can reverse life-threatening respiratory arrest caused by intoxication of opioids. The responders will, prior to registration, accomplish an in-depth overdose and naloxone education, as well as a first aid course aligned with current European and Swedish resuscitation guidelines. The results will be collected through questionnaires to the responder participants, technical data from the responder application, and dispatcher, pre-medical/paramedical and hospital records among others. Both quantitative and qualitative methods will be used. The major question is if the model is feasible in alerting lay persons with naloxone to suspected overdose situations and successfully administer naloxone prior to emergency service arrival. Furthermore, experiences of safety during alerts among volunteer first responders and overdose victims will also be studied.
Our model is unique in its integration with emergency medical dispatch service along with overdose and first aid education prior to participant registration. The respiratory arrest of opioids is an acute life-threatening condition, which - in similarity to cardiac arrests - need emergent actions for survival. A reduced time to naloxone administration through volunteer first responders prior to ambulance arrival could save lives.
Conditions
Interventions
- OTHER
-
Naloxone-responder: A volunteer first responder system connected to emergency dispatch service and alerting overdose and first aid educated volunteers with naloxone to suspected opioid overdoses
The model is a smartphone-based alert system with an app which is connected to dispatcher centers. Volunteer first responders will be alerted in addition to standard emergency medical service (like ambulance) to suspected opioid overdoses and also cardiac arrests. The aim is to see if volunteers equipped with naloxone and with up-do-date knowledge of overdose treatment and first aid can arrive and reverse the condition safely prior to emergency service arrival.
Sponsors & Collaborators
-
SOS Alarm Sverige AB
collaborator UNKNOWN -
Lund University
collaborator OTHER - collaborator OTHER
-
Region Skane
lead OTHER
Principal Investigators
-
Anders C Håkansson, MD, prof. · Malmö Addiction Center, Region Skåne, Sweden
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-09-01
- Primary Completion
- 2027-08-31
- Completion
- 2027-08-31
Countries
- Sweden
Study Locations
More Related Trials
-
Nasal Naloxone for Narcotic Overdose
NCT01912573 ·Status: UNKNOWN ·Phase: PHASE4
-
Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway
NCT01717963 ·Status: COMPLETED ·Phase: PHASE3
-
Increasing Naloxone Access for Persons Who Use Opioids
NCT04303000 ·Status: COMPLETED ·Phase: PHASE4
-
Bioavailability of a New Formulation of Nasal Naloxone for Prehospital Use
NCT02158117 ·Status: COMPLETED ·Phase: PHASE1
-
Nalox-Comm: Naloxone Communication Training for Pharmacists
NCT04677387 ·Status: COMPLETED ·Phase: NA
-
Naloxone Nasal Spray Compared With Naloxone Injection for Opioid Overdoses Outside the Hospital
NCT03518021 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Trial of Intranasal Versus Intravenous Naloxone in Level of Consciousness in Suspected Opioid Overdose
NCT01293058 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Availability of Intranasal Naloxone
NCT05877118 ·Status: RECRUITING ·Phase: NA
-
Naloxone Auto-injection in Healthy Volunteers
NCT05099614 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Overdose Risk Management and Naloxone
NCT03933345 ·Status: UNKNOWN
-
Nalmefene vs Naloxone for the Treatment of Recurrent Respiratory Depression After Opioid Overdose
NCT06408714 ·Status: WITHDRAWN ·Phase: PHASE3
-
Reversal of Opioid-induced Respiratory Depression With Opioid Antagonists
NCT05338632 ·Status: RECRUITING ·Phase: PHASE1
-
A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk
NCT07022717 ·Status: RECRUITING ·Phase: NA
-
Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal
NCT03489161 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers
NCT00134875 ·Status: TERMINATED ·Phase: NA
-
Opioid Rapid Response System: Naloxone Training in Communities
NCT06238128 ·Status: COMPLETED ·Phase: NA
-
Incentivizing Buprenorphine-Naloxone Initiation in Emergency Departments
NCT03821103 ·Status: COMPLETED ·Phase: NA
-
Piloting a Naloxone Intervention in Philadelphia
NCT03305497 ·Status: COMPLETED
-
Bioavailability of Nasal Naloxone and Injected Naloxone Compared
NCT02598856 ·Status: COMPLETED ·Phase: PHASE1
-
Preventing Opioid Overdose Deaths by Empowering Pharmacists to Dispense Naloxone
NCT05093309 ·Status: COMPLETED ·Phase: NA
-
The Feasibility of Using the PulsePoint to Facilitate Overdose Education and Naloxone Distribution
NCT06523985 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Buccal Versus Injectable Naloxone: a Phase I Healthy Volunteer Study
NCT02733822 ·Status: UNKNOWN ·Phase: PHASE1
-
Blood Naloxone Levels Following Intradermal Injection in Humans
NCT05876572 ·Status: WITHDRAWN ·Phase: PHASE4
-
User Acceptability of a Device-Based Opioid Overdose Intervention
NCT04530591 ·Status: COMPLETED
-
Naloxone Auto-injector as a Universal Precaution for Patients With Opioid Use Disorder
NCT02669901 ·Status: COMPLETED ·Phase: NA